Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-31 @ 9:42 PM
Study NCT ID:
NCT04311502
Status:
TERMINATED
Last Update Posted:
2025-08-27
First Post:
2020-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-05
First Submit QC Date:
None
Study First Post Date:
2020-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-18
Results First Submit QC Date:
None
Results First Post Date:
2025-08-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-08
Last Update Post Date:
2025-08-27
Last Update Post Date Type:
ESTIMATED